Metraipolis › archive › dc_a5126cfdbb02

Assessing the Value of Omalizumab for Pediatric Asthma in China: A Multicriteria Decision Analysis — Europe PMC PMID:41095471

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41095471
DOI
10.3390/healthcare13192385
License (as archived)
solo-consultazione
Archived
2026-11-09T19:34:26.401Z
SHA-256 of the archived text
8ef2913e0ed928ed3752c19b39a2e664255851f818bb28b1f481a9e238ea8470
Stable URL of this page
https://metraipolis.com/documento/dc_a5126cfdbb02

How to cite

Assessing the Value of Omalizumab for Pediatric Asthma in China: A Multicriteria Decision Analysis — Europe PMC PMID:41095471 — Europe PMC (en), https://europepmc.org/article/MED/41095471 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a5126cfdbb02 (Metraipolis archive dc_a5126cfdbb02, sha256 8ef2913e0ed928ed3752c19b39a2e664255851f818bb28b1f481a9e238ea8470)
BibTeX
@misc{dca5126cfdbb02,
  title = {Assessing the Value of Omalizumab for Pediatric Asthma in China: A Multicriteria Decision Analysis — Europe PMC PMID:41095471},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41095471},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a5126cfdbb02; sha256 8ef2913e0ed928ed3752c19b39a2e664255851f818bb28b1f481a9e238ea8470},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41095471. Agents can read the archived copy with the MCP tool read_document.